A network approach reveals roles for cancer stem cells in cancer promotion
We talked to team PROMINENT members Professor Allan Balmain and Dr Mark Taylor from the University of California San Francisco about their latest paper ‘Stem-cell states converge in multi-stage cutaneous squamous cell carcinoma development…
In October 2021 we held our first Future Leaders Conference, a chance for the early career members of our community to come together virtually, discuss their work and focus on professional development.
The event was …
Cancers in different parts of the body use unique strategies to avoid attack by the immune system, according to a new study from the Cancer Grand Challenges SPECIFICANCER team and collaborators. The findings also…
How do tumours avoid attack from the immune system?
For some head and neck cancers, the answer lies on the short, p, arm of chromosome 9 – findings from the Cancer Grand Challenges SPECIFICANCER team which could lead…
We (virtually) sat down with John Marioni, new collaborator on the Cancer Grand Challenges IMAXT programme to find out more about his work.
John is a senior group leader at the Cancer Research UK Cambridge Institute,…
OPTIMISTICC’s Cindy Sears is a clinician scientist at Johns Hopkins University School of Medicine and an expert in infectious disease and colorectal cancer.
In July, Cindy and the team shared a new mouse model which…
On the surface, astronomy has little overlap with bioinformatics, mutational analysis and other areas of cancer biology. But, as described by IMAXT’s Nic Walton, an astronomer based at the University of Cambridge, there…
Sir Mike Stratton, based at the Wellcome Sanger Institute in Cambridge, UK, leads the Cancer Grand Challenges Mutographs team.
Mutographs unites genomicists with epidemiologists, building on recent developments in…
Earlier this year, COSMIC - the world's largest and most comprehensive resource for exploring somatic mutations in cancer - celebrated the curation of its 10 millionth mutation.
PhD student Ellie Dunstone discusses…
Johanna Joyce is co-investigator of the Cancer Grand Challenges IMAXT team, based in Lausanne, Switzerland.
We caught up with Johanna to learn how diverse, global collaboration is helping to unlock new information…